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1. INTRODUCTION 
Photodynamic therapy (PDT) or photochemotherapy is a clinically approved, minimally 
invasive therapeutic procedure that can exert a selective cytotoxic activity toward 
malignant cells. The procedure involves administration of a photosensitizing agent (PS) 
followed by irradiation at a wavelength corresponding to an absorbance band of the 
sensitizer. This creates the photodynamic reaction which is tumor and vascular ablative 
(Agostinis et al 2011, Allison and Moghissi 2013).  
Diverse natural PSs as hypericins, hypocrellins and pheiochrome showed great activity 
under PDT protocols (Stockert et al 2004). Other derivatives such as paclitaxel and aloe-
emodin occasioned interesting photodynamic effect on tumor cell cultures (Lee et al 2010, 
Zhang et al 2010).  
Due to the great demand of vegetal compounds that has the international trade; the plant 
cell cultures represent new technologies that extend and enhance the usefulness of plants as 
sources of natural valuable compounds (Acurero 2011).  
One type of in vitro cultures are the calli, characterized for being a disorganized mass of 
undifferentiated tissue with active dividing cells (Vanisree et al 2004). This 
biotechnological tool has been mainly used for the synthesis and extraction of bioactive 
natural products, such as therapeutic drugs. 
Heterophyllaea pustulata Hook f. (Rubiaceae) is a phototoxic plant that grows in the 
Andean northwest of Argentina. The ingestion of different parts of the plant produces toxic 
effect such as dermatitis and blindness on bovine, goat and equine cattle (Hansen and 
Martiarena 1967, Aguirre and Neumann 2001). We have reported previously that 
anthraquinones (AQs) isolated from leaves and stem of H. pustulata exhibited 
photosensitizing properties by generation of singlet oxygen and/or superoxide anion radical 
(Núñez Montoya et al 2005). In other study, we observed that these AQs present increased 
photodynamic activity on cancerous cells (Comini et al 2011). In addition, we showed that 
AQs occasioned photosensitization on Balb/c mice (Núñez Montoya et al 2008). In PDT, 
the current studies are centralized in the characterization of new synthetic and/or natural 
drugs that once photoactivated induce apoptosis, necrosis or autophagy (Rumie Vittar et al 
2010, Sharma and Davids 2012). 
Apoptotic cell death is morphologically characterized by chromatin condensation, cleavage 
of chromosomal DNA into internucleosomal fragments, cell shrinkage, membrane 
blebbing, formation of apoptotic bodies without plasma membrane breakdown. At the 
biochemical level, apoptosis entails the participation of caspases, a family of cysteine 
dependent aspartate-specific proteases, which act in two main converging pathways, 
extrinsic and intrinsic and this signaling finish with the activation of executioner caspases, 
caspase-3 and -7 that cleavage and inactive defined substrates implicated in cells protection 
as (ADP-ribose) polymerase (PARP). In contrast, apoptosis may occur by caspase-
independent pathway implicating apoptosis inducing factor (AIF) and endonuclease G 
(Endo G) (Orrenius et al 2011). In addition to caspases, other proteases are implicated in 
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the cellular death, such as calpains. These proteases belong to a family of calcium activated 
cystein proteases and have function in a wide variety of biological processes, including cell 
division, differentiation, migration, and apoptosis (Kroemer et al 2009). 
While the majority of approved PDT protocols treat superficial lesions of skin and luminal 
organs, interstitial and intra-operative approaches have been investigated for the ablation of 
a broad range of superficial or bulky solid tumors such as breast cancer (Huang et al 2008, 
Master et al 2013). Breast cancer is the most common women's cancer in the world. In 
recent years possibilities of PDT using in breast cancer treatment are analyzed (Płonka and 
Latocha 2012). In this investigation, our studies were mainly focused on the efficacy's 
assessing of natural photosensitizers, Rubiadin and Soranjidiol obtanined from H. pustulata 
callus cultures, on human breast cancer cell lines. The viability, AQs intracellular 
localization and phototoxicity, exploring the cell death mechanism induced on cancer cells 
by the AQ-PDT treatment are analyzed. Also an alternative PDT combination, on which the 
synergic, antagonic or additive Rubiadin- and Soranjidiol- effect was examined. 
 
2. MATERIALS AND METHODS 
2.1. Recollection and in vitro germination of H. pustulata seeds 
The seeds of Heterophyllaea pustulata were collected in Salta province, Argentina, in June 
2008. The material was identified by Prof. Dr. Gloria Barboza (Instituto Multidisciplinario 
de Biología Vegetal, Consejo Nacional de Investigaciones Científicas y Técnica, 
Universidad, Nacional de Córdoba (IMBIV, CONICET, UNC). The seeds were surface 
disinfected by immersion in 70% ethanol for 1 min followed by treatment with 30% 
sodium hypochlorite (NaClO) for 5 min. To remove the traces of chlorines, they were 
washed twice with sterile distilled water. Then, seeds were transferred to Murashige and 
Shoog (MS) medium (Murashige and Skoog 1962) supplemented with vitamins solution 
pH 5.7-5.8 and they were incubated at 28ºC in a culture chamber under a 16 h photoperiod.  
2.2. Callus induction from different explants of H. pustulata 
Leaf, root and stem explants derived from plants of three month age were excised 
longitudinally and placed on basal MS medium supplemented with 1 mg/L of 2,4-
dichlorophenoxyacetic acid (2,4-D, Sigma) for inducing callus. They were incubated in 
darkness in growth chamber at 28ºC. To maintain the callus culture, the proliferated calli 
were regularly subcultured every 3 week intervals on fresh medium with the same 
composition supplemented with antioxidant solution [2 mM L-glutamine (Sigma), 0.285 
mM L- ascorbic acid (Sigma) and 0.26 mM citric acid (Sigma)]. 
2.3. Quantitative analysis of anthraquinones in callus cultures 
Calli were dried in stove at 50°C and the AQs were obtained for successively benzene 
extraction at room temperature. The extracts obtained in each experiment were dried under 
reduced pressure and dissolved in methanol (MeOH; HPLC grade). All samples were 
filtered through a 0.2 mm cellulose acetate membrane filter (Micro Filtration System) 
before HPLC analysis. HPLC analysis (qualitative and quantitative) was performed on a 
Varian Pro Star chromatograph (model 210, series 04171), equipped with a UV–Vis 
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detector and a Microsorb-MV column 100-5 C18 (250 x 4.6 mm i.d., Varian). The mobile 
phase was MeOH–H2O (8:2) at constant flow (1 mL/min) and the injection volume was 20 
µl. The detection was performed at the wavelength of 269 nm. The AQs identification was 
carried out by comparison of the HPLC retention times (tR) with the corresponding 
standards  Rubiadin and Soranjidiol under the same chromatographic conditions. The AQs 
standards were obtained from Nunez-Montoya et al 2003. Each AQ, were quantified 
through the external calibration method (Núñez et al. 2008). Using the calibration curves, 
the concentration of each AQ in extract fraction was calculated by interpolating the area 
under each peak (AUP) for each compound. The seven pointed constructed curves (n=3) 
were linear (correlation coefficients >0.99). 
2.4. Cell culture 
MCF-7c3 human cancer cells transfected with retroviral vector pBabepuro codified cADN 
human CPP32 (procaspase 3) was provided by Dr. CJ Froelich of Northwestern University, 
Evanston, IL, USA. Cells were used as human cancer model and for to assess the 
possibilities of PDT using in solid tumors such as breast cancer. Cultured were cultivated in 
Dulbecco´s modified Eagle medium (DMEM, Gibco BRL) supplemented with 10% v/v 
fetal calf serum (Gibco BRL), 1% glutamax (Gibco BRL), 1% antibiotic/antimycotic 
solution (Gibco BRL) and 1% of piruvate (Hyclone®) and maintained in a humidified 
atmosphere at 37°C and 5% CO2. 
2.5. Photodynamic activity 
Cells were seeded at 2x104cells/mL in multi-well plates and incubated in humidified 
atmosphere comprising 95% air and 5%CO2. When the cells reached 85% confluence were 
immediately treated with 100 μM of AQ (stock solution AQ dissolved in phosphate 
buffered saline, AQPBS), a not toxic dark concentration. We  selected  for  irradiation  the  
absorption  bands  of  AQs  between 410  and  420 nm (Comini et al 2011). The irradiation 
system comprised a non halogen actinic lamp (Phillips 24 V/150 W, 380–480 nm, 1.19 
mW/cm2 (Radiometer Laser Mate-Q, Coherent) with a maximum of 420 nm. All 
irradiations were performed at room temperature. The light dose delivered for the PDT 
treatments were 0.35, 0.7 and 1 J/cm2. Once the treatment finished, the AQ solution was 
replaced by fresh medium and incubated in a humidified atmosphere at 37°C and 5% CO2 
for 24 h. Light control was carried out in parallel. Concluded the treatments, cellular 
viability was determined by the reduction of the tetrazolium salt MTT (3-(4,5-
dimethylthiazolil-2)-2,5-diphenyltetrazolium bromide-Sigma) (Denizot and Lang 1986). 
2.6. Intracellular localization 
Cells (2x104 cells/mL) grown in dish culture plates were treated with AQ maximum 
concentration (no toxic in dark condition) dissolved in PBS during 90 min at 37°C. After 
treatment, solution was recollected and the monolayer was rinsed and fixed with 
formaldehyde vapors for 2 min. Then, they were treated with 1% aluminum potassium 
sulfate (AlK(SO4), Sigma) for 5 min which was used with the purpose to intensify the AQ 
fluorescence. Intracellular localization was visualized under fluorescence microscopy. 
2.7. Nuclear morphology 
Once the photodynamic treatment finished, the detached cells were recollected and 
centrifuged twice at 1000 rpm for 10 min to obtain pellet. Then were fixed with cold 
methanol during 5 min and stained with 1 μg/mL Hoechst 33258 (Ho, Sigma) for 5 min. 
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Attached cells were washed with PBS, fixed with 4% formaldehyde for 15 min and then 
permeabilized with 0.1% Triton X-100/PBS for 5 min at room temperature. Finally, the 
cells were stained with 1 μg/mL Ho for 3 min and rinsed several times with distilled water. 
To corroborate the apoptotic cells, acridine orange (AO, Sigma) was used. Detached cell 
were centrifuged at 2000 rpm for 2 min and the resultant pellet was stained with 10 μg/mL 
AO for 1 min whereas attached cells were washed with PBS and stained with AO, and then 
rinsed to remove any remaining. Nuclear morphology was visualized using a fluorescence 
microscope. 
2.8. Apoptosis analysis 
Cellular apoptosis was evaluated using a Cell Death Detection ELISA Plus kit (Roche). 
This assay allows to measure mononucleosomes and oligonucleosomes from cell lysates 
using monoclonal antibodies targeting DNA and histones in a quantitative photometric 
sandwich enzyme immunoassay. MCF-7c3 cells were treated with 100 μM of Rubiadin or 
Soranjidiol and immediately irradiated with 1 J/cm2. Then, treatment solution was replaced 
for fresh medium and cells were incubated at 37°C. Cell samples were recollected 6, 14 and 
24 h after photodynamic treatment. In parallel, light and dark controls were performed. 
Apoptotic index was calculated for relation between treated cells respect control cells. 
2.9. Western blot analysis 
Cells were incubated with or without 100 μM Rubiadin or Soranjidiol and irradiated with 1 
J/cm2. Then treatment solution was replaced by fresh medium and the monolayer was 
incubated at 37°C. Cell samples were obtained at different times after treatment (1, 3 and 6 
h). Attached and detached cells were harvested and centrifuged at 2000 rpm for 5 min. Cell 
pellets were suspended in lysis buffer RIPA (10 mM Tris–HCl, pH 7.2, 150 mM NaCl, 1% 
Triton X-100, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate, 5 mM EDTA, 
protease inhibitor (1 tablet) and homogenized with syringe. Samples were placed on ice for 
15 min. Protein concentration was determined using the BCA kits. 
Equal amounts of protein (40 μg/mL) were separated by electrophoresis on a SDS-PAGE 
gel and then transferred to a polyvinylidene difluoride (PVDF) membrane (Sigma-Aldrich). 
Blots were soaked in blocking buffer (5% non-fat dry milk) during 2 h, and then incubated 
with specific primary antibodies against caspase-3 (Cell signaling), PARP (Santa Cruz), 
calpain (Cell Signaling) and α-tubulin (Sigma) overnight at 4°C. After exposure, 
membranes were washed with PBS-0.1% Tween, and treated with peroxidase conjugated 
secondary antibody (Cell Signaling) for 2 h. Proteins were visualized using an enhanced 
chemiluminescence detection kit (ECL Kits; Amersham Life Science). 
2.10. DNA fragmentation analysis 
MCF-7c3 cells were treated with 100 μM Rubiadin or Soranjidiol and irradiated with 1 
J/cm2, after treatment AQ solution was replaced for fresh medium. Cells were maintained at 
37°C for 6 h. Concluded photodynamic treatment, cellular samples were harvested with 
trypsin-EDTA (Gibco) and washed with ice-cold PBS by centrifugation at 10000 rpm for 2 
min. Cell pellets were then suspended in 200 μl lysis buffer (50 mM Tris–HCl, 100 mM 
NaCl, 4 mM EDTA, 0.5% SDS, pH 8) with 100 μg proteinase k (stock solution 20 mg/mL, 
Page 6 of 33
Ac
ce
pte
d M
an
us
cri
pt
Sigma) and were incubated at 55°C for 2 h. After addition of 1 M potassium acetate and 
250 μl chloroform during 30 min on ice, the samples were centrifuged at 12000 rpm for 8 
minutes at 4°C. The DNA was extracted and precipitated with 2.5 vol ethanol at -20°C for 
30 minutes, and centrifuged at 12000 rpm for 20 minutes. Pellets were washed with 70% 
ethanol and centrifuged at 12000 rpm for 5 minutes. Pellets were incubated with 0.5% TAE 
buffer (1X solution: 40 mM Tris, 20 mM acetic acid, and 1 mM EDTA) and RNAsa (1 
mg/mL, Invitrogen) for 1 h at 37°C and stored at -20°C. Then, separation by 
electrophoresis was performed on 1.7% agarose containing ethidium bromide. The DNA 
bands were examined using a UV Transilluminator Imaging System. In parallel, controls 
were realized. 
2.11. Phototherapeutic combinations 
MCF-7c3 cells (2x104 cells/mL) were treated with different Rubiadin and Soranjidiol 
combinations (1, 50 and 100 μM), and immediately they were irradiated with 1 J/cm2. 
After treatment the cells were maintained with fresh medium in a humidified atmosphere at 
37°C and 5% CO2 for 24 h. Corresponding controls were realized under the same 
conditions. Cellular viability was determined by MTT assay. Drug interaction and CI were 
determined using median-effect analysis according to the method of Chou and Talalay 
(Chou and Talalay 1984). Combination index (CI) was determined from the CIisobologram 
method using the computer program developed by Chou and Martin (Chou and Martin 
2005). The three possibilities: CI < 1, CI = 1, and CI > 1, indicated synergy, additive effect, 
and antagonism, respectively. 
2.12. Photodynamic effect of commercial anthraquinones 
MCF-7c3 cells were seeded at 2 x104 cells/mL in multi-well plates. When cells presented 
85% confluence, they were incubated with different commercial anthraquinones (1,2- 
dihydroxyanthraquinone called Alizarin and 1,2,4-Trihydroxyanthraquinone called 
Purpurin) concentrations (1, 50 and 100 μM) and immediately were irradiated with 1 J/cm2. 
After phototherapeutic treatment anthraquinone solution was replaced for fresh medium, 
and cells were maintained in a humidified atmosphere at 37°C and 5% CO2 for 24 h. 
Corresponding controls were realized under the same conditions. Cellular viability was 
determined by MTT assay. 
 
3. RESULTS AND DISCUSSION 
3.1. In vitro seed germination of Heterophyllaea pustulata 
In this study, H. pustulata seeds were germinated on MS medium without phytohormones. 
Ideal plants were obtained after 3 months of grown on 0.25% MS medium under a 
photoperiod of 16 h light and 8 h dark (Figure 1A). Only leaves and stems exhibited 
formation of a cellular amorphous orange mass after 15 days of incubation on MS basal 
medium containing 1.0 mg/l 2,4-D (Figure 1B). HPLC analysis revealed presence of 
Rubiadin and Soranjidiol in callus cultured on the MS basal medium supplemented with 1.0 
mg/l of 2,4-D (Figure 1C), their levels were significantly higher than in leaves, stems and 
roots cultures corresponding to 27 and 33.4%, respectively (Table 1). Continuous 
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subcultures of the callus showed oxidative phenotype to the second subculture but this 
phenotype was reverted. Content and concentration of AQs were similar to that determined 
in the initial callus (Figure 1D, Table 2). Based on our results, we suggest that AQs 
production in callus cultures derived from the original plan H. pustulata would be a better 
alternative than the extraction of these compounds from field cultivated plants. 
3.2. Effect of photoactivated AQs on cancer cell viability 
Our previous report showed that Rubiadin and Soranjidiol resulted innocuous in dark 
condition and further activation with visible light induced cytotoxicity on cancer cells 
(Comini et al 2011). In this study, we wondered to evaluate the cellular viability effect of 
different AQs activating light energy (0.35, 0.7 and 1 J/cm2). As shown in Figure 2A both 
AQs, Rubiadin and Soranjidiol, were photochemically active in light dose-dependent 
manner. The photosensitizing ability of Soranjidiol appeared to be more effective than 
Rubiadin, exhibiting a LD50 value with 0.49 J/cm2 irradiation energy, and significant 94% 
cell killing with 1 J/cm2. Instead, Rubiadin showed a LD50 value with 0.66 J/cm2 light dose 
and a 76 % cell reduction at maximum light activation. 
Cell morphology was not affected by light or AQs alone compared to untreated controls 
(data not shown). This fact was confirmed by toluidine blue stained preparations. 
Regarding photodynamic treatment, cells displayed altered morphology, showing higher 
number of cells with swollen membrane and irregular cytoplasm. The phototoxic effect 
observed is thought to be responsible for the rounding-up process. Rubiadin-PDT 
photodamage may cause more injury on MCF-7c3 cells (Figure 2B). Based on our previous 
studies, we suggest that cellular survival diminished in a light dose-dependent manner 
could be related to the ROS production under AQ light activation (Núñez Montoya et al 
2005). 
3.3. AQs intracellular localization 
The subcellular localization of the PS is one of the crucial factors in determining the type of 
cell death due to the chemically generated ROS responsible of the oxidative damage. 
Previously, we have demonstrated that Rubiadin and Soranjidiol produced ROS and were 
incorporated into cancerous cells (Núñez Montoya et al 2005, Comini et al 2011). In this 
study, we have shown that Rubiadin and Soranjidiol can readily pass through cell 
membrane, accumulated the most within cells and exhibited red fluorescence mainly in the 
cytoplasmic region (Figure 3). Cultures did not provide evidence for AQ penetration into 
the cell nucleus. The subcellular AQs pattern allowed us to assume a minimal mutagenesis 
risk which permitted us to continue the studies. 
3.4. AQs sensitize tumor cells leading to apoptosis 
PDT-mediated cell death was assessed by Hoechst/AO and the degree of apoptosis 
quantified by counting condensed and fragmented nuclei post-photosensitization. As 
illustrated in Figure 4, MCF-7c3 control cells (non-irradiated non-treated) had a normal 
nuclear morphology, while those exposed to PDT (Rubiadin or Soranjidiol, 100 µM + 1 
J/cm2) revealed profound nuclei alterations. Nuclear condensation and DNA fragmentation 
were detected in cells under PDT schedule (Rubiadin-PDT or Soranjidiol-PDT).   
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Despite the many characteristics of apoptotic cells, Rubiadin-PDT exhibited more 
percentage of cells with fragmented DNA than Soranjidiol-PDT (77 and 60% respectively), 
indicating that the treatment can rapidly triggered late apoptosis stage (Table 3). We did not 
observe any significant difference in nuclear cell morphology between non-irradiated AQ-
treated cells and irradiated untreated cells. 
To further confirm apoptosis, treated cells were analyzed with the mono- and 
oligonucleosomes induction time course by ELISA (Fig. 5). Rubiadin- and Soranjidiol-
PDT increase the apoptotic index by nearly 7-fold compared to control at 6 h from 
treatment indicating the appearance of mono- and oligonucleosomes. However, solely 
Soranjidiol-PDT sustained the level within first 14 h.  
Apoptotic DNA is a valuable marker of apoptosis because it is a late “point of no return” 
(Rumie Vittar et al 2010, Hooker et al 2012). For this reason, we further investigated the 
AQs-PDT-induced DNA degradation pattern. As shown in Figure 6, Rubiadin-PDT DNA 
laddering actually turned out to be very strong compared to a positive control like STS-
treated MCF-7c3 cells. However, Soranjidiol-PDT failed to induce DNA laddering pattern 
like positive control. These results provided convincing data showing that Rubiadin- and 
Soranjidiol-PDT could induce apoptosis in MCF-7c3 cells, but the molecular events that 
degrade their DNA may do not be similar. 
To analyze the molecular mechanism underlying apoptosis, we determined caspase-3 
activation and detection of intact and cleaved poly-ADP ribose-polymerase that binds at 
DNA strand breaks. As shown in Fig. 7A, Rubiadin-PDT strongly stimulated the caspase-3 
activation (17 kDa fragment) as soon as 1 h post-irradiation which correlated with cleavage 
of PARP (89 kDa). These data demonstrated that Rubiadin-PDT triggered an early 
apoptotic signal that culminated in DNA internucleosomal fragmentation mediated by 
caspase-3. In contrast, we did not observe pro-caspase-3 cleavage after treatment with 
Soranjidiol-PDT (Figure 7B). Surprisingly, we found that calpain (76 kDa) but not caspase-
3 had effect on PARP cleavage (from 116 kDa to 60 kDa and 24 kDa fragments), 
suggesting that cells undergo a non-canonical apoptotic cell death. 
Previously, we have reported non oligonucleosomal DNA fragmentation after PDT and a 
noticeable stage I chromatin condensation and large-scale (50 kb) DNA fragmentation 
(Rumie Vittar et al 2010). More surprising is the fact that upon Soranjidiol-PDT apoptotic 
stimuli, MCF-7c3 cells did display neither internucleosomal-size DNA (180 bp multiples) 
nor large-size DNA fragment (50-300 kb). Several research groups have detected large 
DNA fragments during apoptosis and they proposed that large DNA fragmentation occurs 
before internucleosomal DNA cleavage and these large fragments serve as precursors for 
the smaller DNA fragments (Bortner et al 1995). Consistent with these reports, our 
observations also suggest that under Soranjidiol-PDT treatment the internucleosomal DNA 
cleavage appears delayed. In this regard, a non-canonical mechanism involving caspase-
independent cell death and calpain could explain the delayed DNA degrading into small 
fragments.  
3.5. Photocytotoxic effect of Rubiadin in combination with Soranjidiol 
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Combination of antineoplastic drugs is used, in order to reduce the possible resistance of 
tumor cells and minimize unwanted side effects. Due to interesting photodynamic activity 
occasioned by Rubiadin and Soranjidiol on MCF-7c3 cells, we examine their combined 
effect in order to reduce the AQ dose applied. First, we evaluated the tumor cell viability in 
a wide range of compounds concentrations, comparing their effects with commercial AQs 
(Figure 8A). Interestingly, our results indicated that MCF-7c3 cells were highly sensitive to 
a Rubiadin- and Soranjidiol-PDT treatment compared to commercial anthraquinones 
(Alizarin or 1,2- dihydroxyanthraquinone and 1,2,4-Trihydroxyanthraquinone, commonly 
called Purpurin) under the same therapeutic conditions (Figure 8B). In order to test the 
synergistic effect on inducing tumor cell death, we combined Rubiadin and Soranjidiol in 
different ratios (1:1, 1:50, 1:100, 50:1, 50:50, 50:100, 100:1, 100:50 and 100:100) and 
performed MTT assay (Figure 8C). The graphs and combination indexes from the 
compuSyn software analysis (Figure 8C and Table 4) clearly show that the effects of these 
combined natural compounds were antagonistic or synergistic. The data suggest that doses 
below 50 μM of Rubiadin are not possible with the combined Soranjidiol regimens, but 
these agents can be used in combination for an augmented cytotoxic effect under the 
synergic conditions. Regarding the impact on cell viability, the combined treatment of 50 
μM Rubiadin + 50 μM Soranjidiol-PDT exhibited an attractive inhibitory effect. From data 
analysis, we suggest that Rubiadin and Soranjidiol could be used in synergic PDT 
protocols, one of them with a real therapeutic potential for to be used in tumor treatment. 
 
4. CONCLUSIONS 
We presented experimental evidence that support the antitumor effect of Rubiadin- and 
Soranjidiol-PDT in vitro. Thus, our studies support an approach for intracellular signals 
triggering apoptotic cell death. Furthermore, our studies reveal a novel cancer treatment 
using the photodynamic combination of Rubiadin and Soranjidiol, and we propose that this 
combination might represent an efficient therapeutic strategy. Further studies are definitely 
necessary to validate the real potential in the context of PDT using in vivo tumors. 
Moreover, we have standarized the obtention of callus cultures with high content of AQs, 
and in the future this in vitro strategy might be used to perform a large-scale production 
process.  
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LEGENDS FOR FIGURES   
Figure 1. Germination of Heterophyllaea pustulata, callus induction and anthraquinones 
production. (A) Plant of H. pustulata grown on MS medium after 25 days maintained at 28ºC in 
room culture with 16 h photoperiod. (B) Callus formation from leaves and stems in MS medium 
supplemented with 1.0 mg/l 2,4-dichlorophenoxyacetic acid, 15 days culture old. (C) HPLC 
bencenic extract reveal anthraquinones production from different vegetal explants. (D) HPLC 
anthraquinones pattern in H. pustulata oxidized callus. 
Figure 2. Rubiadin or Soranjidiol-PDT inhibited cancer cells survival in light dose dependent 
manner. (A) Cells were treated with 100 μM Rubiadin or Soranjidiol and exposed to different light 
energy (0.35, 0.7 and 1 J/cm2). The related cell viability was assessed at 24 h by MTT. Data are 
represented as the mean ± S.D. obtained from three independent experiments. (B) MCF-7c3 cells 
were treated with 100 μM Rubiadin or Soranjidiol and irradiated with 1 J/cm2. Changes in cell 
morphology were assessed at 24 h post-PDT. Phase contrast (PC). Toluidine Blue (TB).  
Figure 3. Subcellular localization of Rubiadin and Soranjidiol. Cells were treated with 100 μM by 
90 min and then were observed under fluorescence microscopy. (A) Control; (B) Rubiadin 
fluorescence; (C) Soranjidiol fluorescence. Scale bar: 10 μm. 
Figure 4. Rubiadin- or Soranjidiol-PDT induced apoptotic cell death. MCF-7c3 cells treated with 
PDT regimen (100 μM AQ + 1 J/cm2) were fixed and subjected to Hoechst (Ho) or acridine orange 
(AO) staining to detect apoptotic nuclei. Figures are representative data collected from three 
independent experiments. 
Figure 5. AQ-PDT apoptosis time course in human cancer cell line. Cell were treated with 100 μM 
Rubiadin (A) or Soranjidiol (B) and exposed to 1 J/cm2. Apoptosis was examined at 6, 14 and 24 h 
post-PDT by determining nucleosomal DNA fragmentation. The last bar corresponds to positive 
control DNA-Histone-Complex. Data are represented from three independently performed 
experiments. 
Figure 6. DNA fragmentation after Rubiadin- or Soranjidiol-PDT. DNA fragmentation was 
assessed by a DNA laddering experiment performed on MCF-7c3 cells at 6 h post-PDT. The 
positive control was MCF-7c3 cells treated with 1 μM staurosporine for 6 h (STS). 
Figure 7. Molecular apoptotic profile of Rubiadin- or Soranjidiol-PDT. (A) Caspase-3 and PARP 
cleavage was assessed in MCF-7c3 cells treated with Rubiadin (100 μM + 1 J/cm2). β-Actin is used 
as loading control. (B) Caspase-3, PARP, calpain and α–tubulin levels were assessed in MCF-7c3 
cells treated or not with 100 μM Soranjidiol at various times post-irradiation. STS was used as 
caspase-3 and PARP cleavage positive controls.  
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Figure 8. Rubiadin and Soranjidiol combination synergistically decrease cancer cell viability. (A) 
MCF-7c3 cells were exposed to different AQs concentrations. Cell viability assessed at 24 h by 
MTT assay in cell treated with Rubiadin- PDT (left column graph) or Soranjidiol-PDT (right 
column graph). (B) Photodynamic effect induced by Alizarin and Purpurin. Cells were treated with 
Alizarin (left column graph) or Purpurin (right column graph) at different concentrations and 
irradiated with 1 J/cm2. (C) Cells treated with different Rubiadin and Soranjidiol-PDT combination 
(0, 1, 50, 100 μM + 1 J/cm2). Cell survival was determinate at 24 h. Data are represented as the 
mean ± S.D. obtained from three independent experiments. 
Table 1. Anthraquinones production in callus extract of H. pustulata. Anthraquinone quantification 
from bencenic fraction in root, leaf, stem, and callus. The percentage was calculated by 
interpolating the area under each peak for Rubiadin and Soranjidiol HPLC profile. 
Table 2. Anthraquinones production in oxidized callus extract of H. pustulata. Percentage of AQs 
in bencenic extract obtained from callus was calculated by interpolating the area under each peak 
for Rubiadin and Soranjidiol HPLC profile. 
Table 3. Nuclear morphology after AQs-PDT protocol. Five photographs per well were taken for 
assessed nuclear morphology by fluorescence microscopy.  Non-modified, condensed or 
fragmented nuclei were qualified and quantified by calculating percentage in each experimental 
condition. 
Table 4. Antagonic and synergic effect of Rubiadin/Soranjidiol combination under PDT protocols. 
The values were obtained using the software CompuSyn. CI: Combination index for each 
anthraquinone (CI > 1 antagonic combination, CI < 1 synergic combination). Fa: fraction affected. 
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Bencenic extract Rubiadin Soranjidiol 
Root 8.9% 2.7% 
Leaf 2.3% 2.6% 
Callus 27% 33.4% 
Stem 9.7% 14.1% 
 
Table. 1 
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Table. 2  Bencenic extract Rubiadin Soranjidiol 
Oxidized callus 31% 35% 
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Table. 3 
Conditions Non-modified (%) Condensed (%) Fragmented (%) 
Control 100±5 - - 
Light control 97±5 - 3±1 
Rubiadin 100±4.2 - - 
Soranjidiol 98±3.7 2±1.8 - 
Rubiadin-PDT 19±4 4±2.1 77±4.5 
Soranjidiol-PDT 4±1.5 37±2.2 60±3 
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Rubiadin dose 
(µM) 
Soranjidiol dose  
(µM) 
Fa CI Description 
1 1 0.0010 2.05 Antagonism 
50 1 0.20 1.56 Antagonism 
100 1 0.95 0.19 Synergism 
1 50 0.20 4.73 Antagonism 
50 50 0.96 0.74 Synergism 
100 50 0.97 0.68 Synergism 
1 100 0.61 4.19 Antagonism 
50 100 0.96 1.38 Antagonism 
100 100 0.98 1.13 Antagonism 
 
Table. 4 
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Abstract: Over the past decade the science has studied synthetic photosensitizers used in 
photodynamic therapy (PDT) or photochemotherapy as anticancer candidates. In this context, 
compounds extracted from vegetable species present interesting potential in the cancer field. In 
our laboratory, we studied Heterophyllaea pustulata a phototoxic shrub that habit the northwest 
of Argentina. From this vegetal, by in vitro germination, we obtained Rubiadin and Soranjidiol, two 
anthraquinones that exhibited significant photocytotoxicity on human cancer cells. In addition, the 
fraction obtained from callus cultures allowed us to get a satisfactory content of these compounds 
compared to those found from the original plant. Under PDT regimen, we found that cell 
destruction resulted in a dose‐dependent manner and occasioned apoptosis on photosensitized 
cells. Biochemical analysis revealed the involvement of caspase‐3, PARP cleavage and DNA 
fragmentation in Rubiadin induced apoptosis. Moreover, Soranjidiol‐PDT led to μ‐calpain‐induced 
apoptosis involving caspases‐3‐independent DNA fragmentation. We also showed that both 
anthraquinones are cytoplasmatically distributed and out of nucleus. In addition, we 
demonstrated a synergic cytotoxic effect when we combined them.   
Our data demonstrated that Rubiadin and Soranjidiol could be further considered as natural 
photocytotoxic compounds against cancer cells and callus cultures are a plausible source of these 
anthraquinonic compounds.a 
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